Masimo Co. (NASDAQ:MASI) EVP Yongsam Lee sold 1,078 shares of the stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $152.42, for a total transaction of $164,308.76. Following the completion of the sale, the executive vice president now directly owns 74,078 shares of the company’s stock, valued at approximately $11,290,968.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Yongsam Lee also recently made the following trade(s):

  • On Friday, August 16th, Yongsam Lee sold 2,454 shares of Masimo stock. The shares were sold at an average price of $151.40, for a total transaction of $371,535.60.
  • On Tuesday, August 13th, Yongsam Lee sold 4,981 shares of Masimo stock. The shares were sold at an average price of $153.62, for a total transaction of $765,181.22.
  • On Friday, July 12th, Yongsam Lee sold 5,989 shares of Masimo stock. The shares were sold at an average price of $151.83, for a total transaction of $909,309.87.
  • On Monday, July 15th, Yongsam Lee sold 12,500 shares of Masimo stock. The shares were sold at an average price of $151.82, for a total transaction of $1,897,750.00.
  • On Thursday, June 27th, Yongsam Lee sold 258 shares of Masimo stock. The shares were sold at an average price of $145.00, for a total transaction of $37,410.00.
  • On Monday, June 24th, Yongsam Lee sold 2,371 shares of Masimo stock. The shares were sold at an average price of $145.90, for a total transaction of $345,928.90.
  • On Tuesday, June 18th, Yongsam Lee sold 2,728 shares of Masimo stock. The shares were sold at an average price of $145.98, for a total transaction of $398,233.44.
  • On Thursday, June 20th, Yongsam Lee sold 9,035 shares of Masimo stock. The shares were sold at an average price of $146.60, for a total transaction of $1,324,531.00.

MASI stock opened at $150.39 on Friday. Masimo Co. has a twelve month low of $98.23 and a twelve month high of $160.25. The company has a market capitalization of $8.12 billion, a P/E ratio of 49.63, a PEG ratio of 2.36 and a beta of 1.14. The firm has a 50 day simple moving average of $152.99 and a 200-day simple moving average of $139.61.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, July 31st. The medical equipment provider reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. Masimo had a net margin of 22.15% and a return on equity of 17.82%. The business had revenue of $229.60 million during the quarter, compared to the consensus estimate of $222.46 million. During the same quarter last year, the company earned $0.73 earnings per share. The business’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, research analysts forecast that Masimo Co. will post 3.15 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. MetLife Investment Advisors LLC lifted its stake in Masimo by 0.3% during the first quarter. MetLife Investment Advisors LLC now owns 29,816 shares of the medical equipment provider’s stock worth $4,123,000 after purchasing an additional 90 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in Masimo by 0.5% during the first quarter. PNC Financial Services Group Inc. now owns 23,693 shares of the medical equipment provider’s stock worth $3,276,000 after purchasing an additional 116 shares during the last quarter. Arizona State Retirement System lifted its stake in Masimo by 0.4% during the first quarter. Arizona State Retirement System now owns 35,126 shares of the medical equipment provider’s stock worth $4,857,000 after purchasing an additional 132 shares during the last quarter. Bridge City Capital LLC lifted its stake in Masimo by 0.5% during the second quarter. Bridge City Capital LLC now owns 29,426 shares of the medical equipment provider’s stock worth $4,379,000 after purchasing an additional 144 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan lifted its stake in Masimo by 1.7% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,040 shares of the medical equipment provider’s stock worth $1,345,000 after purchasing an additional 150 shares during the last quarter. Hedge funds and other institutional investors own 82.91% of the company’s stock.

MASI has been the subject of a number of recent analyst reports. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $153.00 price target for the company in a research report on Wednesday, May 8th. Needham & Company LLC reissued a “buy” rating and set a $158.00 price target (up previously from $155.00) on shares of Masimo in a research report on Tuesday, May 7th. BTIG Research reissued a “hold” rating on shares of Masimo in a research report on Thursday, August 1st. Stifel Nicolaus raised their price target on shares of Masimo from $165.00 to $170.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Finally, UBS Group raised their price target on shares of Masimo from $172.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. Masimo currently has a consensus rating of “Buy” and an average target price of $159.25.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More: How to Invest in Marijuana Stocks

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.